Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01123837 · ClinicalTrials.gov registry record · NA

A Closer Look at the Effect of Dextrose on Postoperative Nausea and Vomiting

A NA study, sponsored by Loma Linda University.

Completed
Registry status
NA
Development phase
202
Enrollment target

NCT01123837: Completed NA study, sponsored by Loma Linda University.

NCT01123837 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 202 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01123837, a NA study, has completed, sponsored by Loma Linda University.

COMPLETED
Registry status
NA
Development phase
202 participants
Enrollment target

Study Summary

"The purpose of this investigator-initiated study is to see if giving dextrose fluid in the veins (IV) decreases the risk of postoperative nausea and vomiting (PONV) in female urologic, gynecologic and breast outpatient surgery patients and at what blood surgery level. The reason for this study is that IV dextrose has been shown to decrease the incidence of PONV and the use of medications to treat PONV, while leading to sooner discharge after surgery. This can decrease overall healthcare cost and improving patient satisfaction."

Primary Outcome

The primary outcome measures will be the severity and incidence of PONV along with the type and number of rescue medications given at 0,30,60, and 120 minutes PACU time and the next morning.

Interventions

  • OTHER Intravenous fluid
  • OTHER D5LR or lactated ringers

Trial Details

FieldValue
Enrollment Target 202 participants
Start Date 2010-04
Est. Completion 2013-09
Phase NA
Loma Linda University

237 total trials

What the finished NCT01123837 record still lists

NCT01123837 is an interventional study that assigns participants to a tested intervention. The registered 202 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).

The record links to 0 conditions, and to 2 interventions - of which Intravenous fluid is the first listed.

NCT01123837 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01123837 about?

NCT01123837 is a clinical study titled "A Closer Look at the Effect of Dextrose on Postoperative Nausea and Vomiting". "The purpose of this investigator-initiated study is to see if giving dextrose fluid in the veins (IV) decreases the risk of postoperative nausea and vomiting (PONV) in female urologic, gynecologic and breast outpatient surgery patients and at what blood surgery level. The reason for this study is t...

What is the current status of trial NCT01123837?

This trial is currently completed. It is a NA study. The enrollment target is 202 participants. The study started on 2010-04. Estimated completion is 2013-09.

What interventions are being tested in trial NCT01123837?

The interventions under investigation include: Intravenous fluid (OTHER), D5LR or lactated ringers (OTHER).

Who is sponsoring clinical trial NCT01123837?

This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01123837's enrollment target sits among peer trials

202 505th of 2000 higher than 1,495 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05272254 · 202 participants · Phase 2

    Povidone Iodine Efficacy Study

  • NCT05701280 · 202 participants · NA

    Pilot/Pivotal Study of DBS+Rehab After Stroke

  • NCT05932589 · 202 participants

    Neurophysiologic Biomarkers in Rett Syndrome

  • NCT06014931 · 202 participants · NA

    Telehealth-enhanced Patient-oriented Recovery Trajectory After Intensive Care

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01123837, the US trial registry maintained by the National Library of Medicine. NCT01123837 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.